The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is the largest pediatric hematology, oncology and blood and marrow transplant program in the western United States. The Las Madrinas Endowment for Hematopoietic Stem Cell Research supports the ongoing development of the CCCBD’s Cell Therapy Program, aimed at accelerating the developments of cell and immune-based treatments.
This game-changing program, led by Alan Wayne, MD and Michael Pulsipher, MD, is responsible for treating the first-ever Children’s Hospital Los Angeles patients with engineered T-cells. All three patients are now in remission. Ongoing trials supported by our endowment hold tremendous potential for children who have disease relapse or have not responded to traditional cancer therapy. Thanks to the Las Madrinas Endowment, Children’s Hospital Los Angeles researchers have the support they need to develop new therapies in hopes of improving the lives of children with cancer and other life-threatening conditions.
